Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 15:12:975398.
doi: 10.3389/fcimb.2022.975398. eCollection 2022.

Serological cross-reactivity among common flaviviruses

Affiliations
Review

Serological cross-reactivity among common flaviviruses

Kai Rol Chan et al. Front Cell Infect Microbiol. .

Abstract

The Flavivirus genus is made up of viruses that are either mosquito-borne or tick-borne and other viruses transmitted by unknown vectors. Flaviviruses present a significant threat to global health and infect up to 400 million of people annually. As the climate continues to change throughout the world, these viruses have become prominent infections, with increasing number of infections being detected beyond tropical borders. These include dengue virus (DENV), West Nile virus (WNV), Japanese encephalitis virus (JEV), and Zika virus (ZIKV). Several highly conserved epitopes of flaviviruses had been identified and reported to interact with antibodies, which lead to cross-reactivity results. The major interest of this review paper is mainly focused on the serological cross-reactivity between DENV serotypes, ZIKV, WNV, and JEV. Direct and molecular techniques are required in the diagnosis of Flavivirus-associated human disease. In this review, the serological assays such as neutralization tests, enzyme-linked immunosorbent assay, hemagglutination-inhibition test, Western blot test, and immunofluorescence test will be discussed. Serological assays that have been developed are able to detect different immunoglobulin isotypes (IgM, IgG, and IgA); however, it is challenging when interpreting the serological results due to the broad antigenic cross-reactivity of antibodies to these viruses. However, the neutralization tests are still considered as the gold standard to differentiate these flaviviruses.

Keywords: antibodies; antibody assays; cross-protection; flaviviruses; serological cross reactivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flavivirus genomic organization. (A) A schematic representation of Flavivirus genomic organization. (B) Primary structure of Flavivirus E protein ectodomain showing EDI (pink), EDII (light blue), and EDIII (orange). The stem region and the transmembrane (TM) domain represented in black and blue, respectively.
Figure 2
Figure 2
The protein-dimer structure of DENV1 E protein and EAEPPFG epitope located at domain III. The brown, black, and blue circle represent the domain I, domain II, and domain III, respectively, in one E protein monomer. Another monomer is colored gray. The red spheres located in EDIII represent the EAEPPEG epitope.
Figure 3
Figure 3
Structure of 2A10G6 epitope of DENV1 E protein. The 98DRXW101 motif is labeled and colored as blue, purple, yellow, and orange, respectively, according to the residue sequence.

Similar articles

Cited by

References

    1. Abbink P., Larocca R. A., Dejnirattisai W., Peterson R., Nkolola J. P., Borducchi E. N., et al. . (2018). Therapeutic and protective efficacy of a dengue antibody against zika infection in rhesus monkeys. Nat. Med. 24 (6), 721–723. doi: 10.1038/s41591-018-0056-0 - DOI - PMC - PubMed
    1. Alcon S., Talarmin A., Debruyne M., Falconar A., Deubel V., Flamand M. (2002). Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40 (2), 376–381. doi: 10.1128/jcm.40.02.376-381.2002 - DOI - PMC - PubMed
    1. Allwinn R., Doerr H., Emmerich P., Schmitz H., Preiser W. (2002). Cross-reactivity in flavivirus serology: new implications of an old finding? Med. Microbiol. Immunol. 190 (4), 199–202. doi: 10.1007/s00430-001-0107-9 - DOI - PubMed
    1. Anantapreecha S., A-Nuegoonpipat A., Prakrong S., Chanama S., Sa-Ngasang A., Sawanpanyalert P., et al. . (2007). Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection. Japanese J. Infect. Dis. 60 (5), 267–270. - PubMed
    1. Anderson K. B., Gibbons R. V., Thomas S. J., Rothman A. L., Nisalak A., Berkelman R. L., et al. . (2011). Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Negl. Trop. Dis. 5 (10), e1311. doi: 10.1371/journal.pntd.0001311 - DOI - PMC - PubMed

Publication types